Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
Serelaxin 通过 RXFP1 抑制内皮细胞向间质细胞的转化，从而减轻心脏纤维化
期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.38640
Wilhelmi Tim, Xu Xingbo, Tan Xiaoying, Hulshoff Melanie S, Maamari Sabine, Sossalla Samuel, Zeisberg Michael, Zeisberg Elisabeth M
